![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 16, Issue 12, 5579-5591, December 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and CREB-binding Protein
Department of Pharmacology, College of Medicine, National Taiwan University, Taipei 10018, Taiwan
Submitted August 18, 2005;
Accepted September 21, 2005
Monitoring Editor: J. Silvio Gutkind
Inhibition of ubiquitin-proteasome pathway has been shown to be a promising strategy for the treatment of inflammation and cancer. Here, we show that proteasome inhibitors MG132, PSI-1, and lactacystin induce COX-2 expression via enhancing gene transcription rather than preventing protein degradation in the human alveolar NCI-H292 and A549, and gastric AGS epithelial cells. NF-IL6 and CRE, but not NF-
B elements on the COX-2 promoter were involved in the gene transcription event. The binding of CCAAT/enhancer binding protein (C/EBP)
and C/EBP
to the CRE and NF-IL6 elements, as well as the recruitment of CBP and the enhancement of histone H3 and H4 acetylation on the COX-2 promoter was enhanced by MG132. However, it did not affect the total protein levels of C/EBP and C/EBP. MG132-induced DNA-binding activity of C/EBP, but not C/EBP was regulated by p38, PI3K, Src, and protein kinase C. Small interfering RNA of C/EBP suppressed COX-2 expression, further strengthening the role of C/EBP in COX-2 gene transcription. In addition, the generation of intracellular reactive oxygen species (ROS) in response to MG132 contributed to the activation of MAPKs and Akt. These findings reveal that the induction of COX-2 transcription induced by proteasome inhibitors requires ROS-dependent protein kinases activation and the subsequent recruitments of C/EBP and CBP.
Abbreviations used: NF-B, nuclear factor B; NF-IL6, nuclear factor for interleukin 6; IL, interleukin; PI3K, phosphatidylinositol 3-kinase; RT-PCR, reverse transcription-polymerase chain reaction; TNF, tumor necrosis factor.
* These authors contributed equally to this work.
Address correspondence to: Ching-Chow Chen (ccchen{at}ha.mc.ntu.edu.tw).
This article has been cited by other articles:
|
|
 |
|
  A. G. Granja, E. G. Sanchez, P. Sabina, M. Fresno, and Y. Revilla African Swine Fever Virus Blocks the Host Cell Antiviral Inflammatory Response through a Direct Inhibition of PKC-{theta}-Mediated p300 Transactivation J. Virol., January 15, 2009; 83(2): 969 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-L. Wang, Y.-C. Lee, W.-M. Yang, W.-C. Chang, and J.-M. Wang Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription Nucleic Acids Res., November 1, 2008; 36(19): 6066 - 6079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sun, W.-C. Chung, S.-H. Ryu, Z. Ju, H. T. Tran, E. Kim, J. M. Kurie, and J. S. Koo Cyclic AMP-Responsive Element Binding Protein- and Nuclear Factor-{kappa}B-Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis Cancer Prevention Research, October 1, 2008; 1(5): 316 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-J. Chen, C.-W. Chou, Y.-F. Chang, and C.-C. Chen Proteasome Inhibitors Enhance TRAIL-Induced Apoptosis through the Intronic Regulation of DR5: Involvement of NF-{kappa}B and Reactive Oxygen Species-Mediated p53 Activation J. Immunol., June 15, 2008; 180(12): 8030 - 8039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Song, S. Guha, K. Liu, N. S Buttar, and R. S Bresalier COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma Gut, November 1, 2007; 56(11): 1512 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-C. Jang, S.-H. Sung, J.-G. Park, J.-W. Park, J. H. Bae, D. H. Shin, G.-Y. Park, S.-B. Han, and S.-I. Suh Glucosamine Hydrochloride Specifically Inhibits COX-2 by Preventing COX-2 N-Glycosylation and by Increasing COX-2 Protein Turnover in a Proteasome-dependent Manner J. Biol. Chem., September 21, 2007; 282(38): 27622 - 27632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. S. Park, J. Kim, Y. Misonou, R. Takamiya, M. Takahashi, M. R. Freeman, and N. Taniguchi Acrolein Induces Cyclooxygenase-2 and Prostaglandin Production in Human Umbilical Vein Endothelial Cells: Roles of p38 MAP Kinase Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1319 - 1325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yakar, N. P. Nunez, P. Pennisi, P. Brodt, H. Sun, L. Fallavollita, H. Zhao, L. Scavo, R. Novosyadlyy, N. Kurshan, et al. Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones Endocrinology, December 1, 2006; 147(12): 5826 - 5834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Alarid Lives and Times of Nuclear Receptors Mol. Endocrinol., September 1, 2006; 20(9): 1972 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gao, L. Kramer, M. Rahmani, P. Dent, and S. Grant The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down-Regulation of Mcl-1 through a Transcriptional Mechanism Mol. Pharmacol., August 1, 2006; 70(2): 645 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Eisinger, L. D. Nadauld, D. N. Shelton, P. W. Peterson, R. A. Phelps, S. Chidester, D. M. Stafforini, S. M. Prescott, and D. A. Jones The Adenomatous Polyposis Coli Tumor Suppressor Gene Regulates Expression of Cyclooxygenase-2 by a Mechanism That Involves Retinoic Acid J. Biol. Chem., July 21, 2006; 281(29): 20474 - 20482. [Abstract] [Full Text] [PDF]
|
|
